KRYS stock

Krystal Biotech Inc (KRYS) financials · rev $389.1M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Krystal Biotech Inc (KRYS) rev $389.1M.

Cached annual income statement
LineFY2025FY2024
Revenue$389.1M$290.5M
Operating Income$161.3M$65.7M
Net Income$204.8M$89.2M
EPS (Diluted)$6.84$3.00
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.33B$1.06B
Current Assets$1.02B$742.0M
Cash & Equivalents$496.3M$344.9M
Inventory$40.5M$26.5M
PP&E$150.8M$155.2M
Total Liabilities$114.2M$109.5M
Current Liabilities$102.9M$102.0M
Shareholders' Equity$1.22B$946.4M
Retained Earnings$24.2M-$180.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$200.9M$123.4M
CapEx$12.0M$4.24M
Investing Cash Flow-$58.4M-$163.4M
Financing Cash Flow$8.71M$27.0M
Net Change in Cash$151.4M-$13.5M
Free Cash Flow$188.9M$119.2M
These statements as JSON? API free 100/day

FAQ

What is KRYS P/E and revenue?

Krystal Biotech Inc (KRYS) rev $389.1M.

What is KRYS revenue?

Krystal Biotech Inc last cached revenue is $389.1M (FY2025).

Is KRYS profitable?

Krystal Biotech Inc last cached net income is $204.8M (FY2025).

What are KRYS total assets?

Krystal Biotech Inc last cached total assets are $1.33B (FY2025).

What is KRYS free cash flow?

Krystal Biotech Inc last cached free cash flow is $188.9M (FY2025).

Not investment advice. Cached statements, not a live tape.